The caspase-6–p62 axis modulates p62 droplets based autophagy in a dominant-negative manner
dc.contributor.author | Valionyte, E | |
dc.contributor.author | Yang, Y | |
dc.contributor.author | Griffiths, SA | |
dc.contributor.author | Bone, AT | |
dc.contributor.author | Barrow, ER | |
dc.contributor.author | Sharma, Vikram | |
dc.contributor.author | Lu, B | |
dc.contributor.author | Luo, Shouqing | |
dc.date.accessioned | 2022-03-07T11:23:12Z | |
dc.date.issued | 2021-12-03 | |
dc.identifier.issn | 1350-9047 | |
dc.identifier.issn | 1476-5403 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/18899 | |
dc.description.abstract |
<jats:title>Abstract</jats:title><jats:p>SQSTM1/p62, as a major autophagy receptor, forms droplets that are critical for cargo recognition, nucleation, and clearance. p62 droplets also function as liquid assembly platforms to allow the formation of autophagosomes at their surfaces. It is unknown how p62-droplet formation is regulated under physiological or pathological conditions. Here, we report that p62-droplet formation is selectively blocked by inflammatory toxicity, which induces cleavage of p62 by caspase-6 at a novel cleavage site D256, a conserved site across human, mouse, rat, and zebrafish. The N-terminal cleavage product is relatively stable, whereas the C-terminal product appears undetectable. Using a variety of cellular models, we show that the p62 N-terminal caspase-6 cleavage product (p62-N) plays a dominant-negative role to block p62-droplet formation. In vitro p62 phase separation assays confirm this observation. Dominant-negative regulation of p62-droplet formation by caspase-6 cleavage attenuates p62 droplets dependent autophagosome formation. Our study suggests a novel pathway to modulate autophagy through the caspase-6–p62 axis under certain stress stimuli.</jats:p> | |
dc.format.extent | 1211-1227 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Springer Science and Business Media LLC | |
dc.subject | Animals | |
dc.subject | Autophagosomes | |
dc.subject | Autophagy | |
dc.subject | Caspase 6 | |
dc.subject | Humans | |
dc.subject | Mice | |
dc.subject | Rats | |
dc.subject | Sequestosome-1 Protein | |
dc.subject | Signal Transduction | |
dc.subject | Zebrafish | |
dc.title | The caspase-6–p62 axis modulates p62 droplets based autophagy in a dominant-negative manner | |
dc.type | journal-article | |
dc.type | Journal Article | |
dc.type | Research Support, Non-U.S. Gov't | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000725940400002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 6 | |
plymouth.volume | 29 | |
plymouth.publication-status | Published | |
plymouth.journal | Cell Death & Differentiation | |
dc.identifier.doi | 10.1038/s41418-021-00912-x | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/Peninsula Medical School | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Biomedical Sciences | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
plymouth.organisational-group | /Plymouth/Users by role/Researchers in ResearchFish submission | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2021-11-22 | |
dc.rights.embargodate | 2022-3-8 | |
dc.identifier.eissn | 1476-5403 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1038/s41418-021-00912-x | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-12-03 | |
rioxxterms.type | Journal Article/Review | |
plymouth.funder | Tackling autophagy and apoptosis for the potential therapy of Huntington's Disease::MRC |